Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of Apremilast in Active Psoriatic Arthritis
NCT00456092Phase 2Completed
- Sponsor
- Amgen
- Start
- Mar 2007
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of apremilast in psoriatic arthritis (PsA), sponsored by Amgen. Started Mar 2007; status: completed.
02
Drugs
apremilast
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on NCT00456092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00456092.